Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2020-07-28 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notice scheduling a conference call to discuss the 1QFY21 financial results of Indoco Remedies Limited. It includes details about the date, time, participants, and dial-in information for the call. There is no actual financial data or analysis presented in the document, only an announcement of the upcoming call. This matches the definition of a Call Transcript (CT) document type, except this is not the transcript itself but a scheduling notice. However, since the document is about the conference call meeting schedule and not the transcript or the financial results themselves, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the call schedule pursuant to SEBI regulations. The document length is 7808 characters, which is not extremely short, but the content is clearly an announcement rather than a report or transcript. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-07-28 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a notice regarding the publication of a Board Meeting Notice, as indicated by the subject line 'Sub: Publication of Board Meeting Notice' and the content describing the publication of the notice in newspapers. It is addressed to stock exchanges and includes details about the notice publication. There is no financial data, management discussion, or detailed report content. The document is a formal announcement about the notice publication rather than the notice itself or any financial report. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-07-13 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. It contains a confirmation certificate from the Registrar and Share Transfer Agent about dematerialisation of securities for the quarter ended June 30, 2020. The document is short (4414 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is an official regulatory filing related to securities processing and compliance with SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS).
2020-07-10 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about an upcoming Board Meeting scheduled to consider and approve the unaudited financial results for the quarter ended June 30, 2020. It is dated July 10, 2020, and is addressed to the BSE and NSE. The document does not contain any financial data or results itself, only an announcement of the meeting where such results will be discussed. The length is only 1131 characters, indicating it is a brief notice rather than a full report. According to the rules, such a notice is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain the actual financial report or detailed data. It is not an Interim/Quarterly Report (IR) because it does not include substantive financial data or analysis, only a meeting notice.
2020-07-10 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window for insiders due to upcoming financial results. It references regulatory provisions related to insider trading and specifies the closure period around the announcement of unaudited financial results for the quarter ended June 30, 2020. The document does not contain any financial data, results, or detailed report content itself, but is an announcement related to trading restrictions ahead of a financial report. The document length is short (1603 characters), and it serves as a notification rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement related to compliance and insider trading rules, not as the financial report or earnings release itself.
2020-07-01 English
Related Party Transactions
Regulatory Filings
2020-06-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.